Sanofi’s Dupixent Has Greater Benefit In COPD Patients With Higher Type II Inflammation

Full Pivotal Data Suggests

Man in polluted city holding a face mask over his face
Air Pollution Is One Of The Causes of COPD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D